ARCHIVES

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

This article is from The Cancer Letter archive.

Vol. 25 No. 42 | November 5, 1999

Download PDF Visit The Full Archive

Related Articles

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014